James A. Shayman

James Alan Shayman is an American physician scientist, nephrologist, and pharmacologist. He is Professor of Internal Medicine and Pharmacology and the Agnes C. And Frank D. McKay Professor at the Medical School of the University of Michigan. He also serves as a staff nephrologist at the Ann Arbor Veterans Administration Medical Center.

Shayman's research interests span the study of lysosomal biology and related disorders. His group is most known for the development of small-molecule inhibitors of glycosphingolipid synthesis and their use in lysosomal glycosphingolipid storage disorders. His team also discovered and characterized a novel lysosomal phospholipase A2, PLA2G15 and is investigating its role in phospholipidosis. He has published over 160 articles.

Shayman is a Fellow of the American Heart Association and American Society of Nephrology as well as a Life Fellow of Clare Hall at the University of Cambridge. He has served as an Associate Editor for the ''Journal of Clinical Investigation'' and ''Translational Research'' and is serving in the same role for the ''Journal of the American Society of Nephrology''. Provided by Wikipedia